ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
20 announcements with these filters
Natraj Proteins Ltd reported revenue from operations of ₹18.2 Cr (-32.3% YoY) and net profit of ₹0.3 Cr for Q2 FY27.
Natraj Proteins intimated a board meeting on 29 October 2026 to consider unaudited results for the quarter and half-year ended 30 September 2026. Trading window remains closed until 48 hours after results are declared.
Natraj Proteins Ltd submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Natraj Proteins Limited re-appointed Mr. Sharad Kumar Jain as Executive Director for a 36-month term effective October 1, 2026.
Natraj Proteins Limited submitted proceedings of its 35th Annual General Meeting held on September 29, 2026. Key resolutions included adopting financial statements and re-appointing directors.
The company dispatched letters to shareholders with unregistered email addresses, informing them about the availability of the Annual Report and AGM notice.
Natraj Proteins filed its 35th Annual Report for FY 2025-26 with the AGM notice. The report recaps existing crushing and refining capacity under Regulation 34(1).
Natraj Proteins Limited announced its 35th Annual General Meeting will be held on September 29, 2026. Share transfer books will be closed from September 23 to 29, 2026.
Natraj Proteins has re-appointed Shri Sharad Kumar Jain as Whole Time Director for a three-year term effective October 1, 2026, subject to shareholder approval.
Natraj Proteins has appointed M/s Yogesh Chourasia and Associates as the Cost Auditor for the financial year 2026-27. This is a routine statutory appointment.
Natraj Proteins Ltd reported revenue from operations of ₹31.4 Cr (+18.0% YoY) and net profit of ₹2.1 Cr for Q1 FY27.
Natraj Proteins has scheduled a board meeting for August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Natraj Proteins submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report details regulatory compliance status with no material fines levied.
Natraj Proteins Ltd reported revenue from operations of ₹18.9 Cr (-18.2% YoY) and net profit of ₹1.1 Cr (-15.4% YoY) for Q4 FY26.
Natraj Proteins reported annual total income of ₹101.39 Crore for FY2026. The audited results show a net profit of ₹1.14 Crore for the fiscal year.
Natraj Proteins Ltd scheduled a board meeting for May 22, 2026. Directors will consider and approve audited financial results for the year ended March 2026.
Natraj Proteins Ltd dispatched KYC update letters to shareholders holding physical securities. The initiative ensures compliance with SEBI mandates for electronic payment of future dividends.
Natraj Proteins Ltd confirmed it does not meet the SEBI criteria for a 'Large Corporate' for the financial year ended March 31, 2026. The company reported outstanding borrowings of ₹36.02 Crore. Consequently, the requirement for filing annual disclosures under the Large Corporate framework does not apply.
Natraj Proteins Ltd submitted a compliance certificate for the quarter ended March 31, 2026, regarding Regulation 74(5) of SEBI Regulations. The filing confirms that securities received for dematerialisation were processed and listed on the relevant stock exchanges within the mandated 15-day timeframe.
Natraj Proteins Ltd reported net profit of ₹2.9 Cr for Q3 FY26.